All News

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

The FDA has given final approval to Aurobindo Pharma Limited for dalfampridine extended-release tablets (10 mg).

Characterizing a patient’s symptoms may improve sleep problems.

Most of the Ebola-related deaths in West Africa could have been prevented, experts say.

Officials with AstraZeneca recently announced that the FDA has expanded the indication of its 80/4.5 mcg budesonide and formoterol fumarate dihydrate inhalation aerosol (Symbicort), approving the drug for the treatment of asthma in patients aged 6 to 12 years.

Excessive amounts of the toxic substance belladonna have been found in certain homeopathic teething tablets, FDA officials confirmed in an announcement.

In a study published in the Journal of Clinical Investigation, the researchers demonstrated a way to promote sensory neuron growth by blocking a specific molecular signaling pathway.

In Massachusetts, unique occurrences of sudden, onset amnesia and acute, complete, and bilateral ischemia of the hippocampus were identified in a number of individuals.

Diabetes-related outcomes significantly differ by state and insurance type.

Trump Administration reduces open enrollment advertisements by $5 million.

A recently-published Institute for Safe Medication Practices (ISMP) report details updated concerns about newer drugs used to treat hepatitis C virus (HCV).

Increased use of biosimilars could create sustainable care for multiple chronic diseases.

Utilization of biosimilars has the potential to overhaul cancer treatment.

Some specialists charge privately-insured patients 6 times as much as they charge Medicare.

Early-onset schizophrenia may predict a diabetes diagnosis.

Top articles of the week from Specialty Pharmacy Times.

The FDA has approved Ironwood and Allergan’s Linzess (linaclotide) for an additional dosing of 72 mcg.

The new test service helps physicians assess patient’s responses to antiretroviral therapy for HBV.

Cancer cells learn to cope with large scale DNA changes.

Top news of the day from across the health care landscape.

The CRTC1 protein and the FGF1 gene are critical for memory.

Top news of the day from across the healthcare landscape.

Pharmacists continue to rank big in lists that highlight the profession’s value.

Simeprevir was approved by the FDA in late 2013 for hepatitis C virus.

Certain measurements of drug costs do not show the whole picture, and can lead to an inaccurate picture of the gross spend by the customer, and an overstatement of the profits made by manufacturers, according to the study.

LinkedIn also provides a platform for engagement and thought leadership.

A few things I learned in my first MBA course

Dan Steiber, RPh, to expand responsibilities to include overseeing all strategic business services for Specialty Pharmacy Times.